Skip to main content
Erschienen in: The Indian Journal of Pediatrics 8/2020

30.03.2020 | Review Article

Current Perspectives in Management of Edema in Nephrotic Syndrome

verfasst von: Jitendra Meena, Arvind Bagga

Erschienen in: Indian Journal of Pediatrics | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Idiopathic nephrotic syndrome is the most common glomerulopathy in childhood characterised by heavy proteinuria, hypoalbuminemia and edema. Most of the patients have mild and transient edema but those with difficult to treat nephrotic syndrome can develop severe edema which may have serious consequences such as immobility, cellulitis and peritonitis. Understanding of the pathophysiology of edema is still evolving with recent research elucidating newer mechanism of sodium retention through plasmin mediated epithelial sodium channel activation in collecting duct. Patients with mild edema do not require specific diuretic therapy as it improves with steroid induced diuresis. In this review, the authors describe the current perspective in management of moderate to severe edema in childhood nephrotic syndrome including various parameters to assess intravascular volume status which is important for planning overall treatment strategy. Then they briefly discuss about various classes of diuretics, aquaretics and evidence based use of furosemide albumin combination therapy for treatment of edema. Management strategy for a small proportion of patients, who are unresponsive to furosemide therapy, includes diuretic synergism, intravenous furosemide albumin combination therapy and continuous intravenous furosemide infusion.
Literatur
1.
Zurück zum Zitat Epstein AA. Concerning the causation of edema in chronic parenchymatous nephritis: method for its alleviation. Am J Med. 1952;13:556–61.PubMed Epstein AA. Concerning the causation of edema in chronic parenchymatous nephritis: method for its alleviation. Am J Med. 1952;13:556–61.PubMed
2.
Zurück zum Zitat Dorhout EJ, Roos JC, Boer P, Yoe OH, Simatupang TA. Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med. 1979;67:378–84.PubMed Dorhout EJ, Roos JC, Boer P, Yoe OH, Simatupang TA. Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med. 1979;67:378–84.PubMed
3.
Zurück zum Zitat Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82:635–42.PubMed Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82:635–42.PubMed
4.
Zurück zum Zitat Ellis D. Pathophysiology, evaluation, and management of edema in childhood nephrotic syndrome. Front Pediatr. 2016;3:111.PubMedPubMedCentral Ellis D. Pathophysiology, evaluation, and management of edema in childhood nephrotic syndrome. Front Pediatr. 2016;3:111.PubMedPubMedCentral
5.
Zurück zum Zitat Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron. 1984;37:43–8.PubMed Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron. 1984;37:43–8.PubMed
6.
Zurück zum Zitat Usberti M, Federico S, Meccariello S, et al. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int. 1984;25:422–9.PubMed Usberti M, Federico S, Meccariello S, et al. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int. 1984;25:422–9.PubMed
7.
Zurück zum Zitat Bagga A. Revised guidelines for management of steroid-sensitive nephrotic syndrome. Indian J Nephrol. 2008;18:31–9.PubMedPubMedCentral Bagga A. Revised guidelines for management of steroid-sensitive nephrotic syndrome. Indian J Nephrol. 2008;18:31–9.PubMedPubMedCentral
8.
Zurück zum Zitat Pasini A, Benetti E, Conti G, et al. The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr. 2017;43:41.PubMedPubMedCentral Pasini A, Benetti E, Conti G, et al. The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr. 2017;43:41.PubMedPubMedCentral
9.
Zurück zum Zitat Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet. 1982;2:1237–40.PubMed Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet. 1982;2:1237–40.PubMed
10.
Zurück zum Zitat Usberti M, Gazzotti RM, Poiesi C, D’Avanzo L, Ghielmi S. Considerations on the sodium retention in nephrotic syndrome. Am J Nephrol. 1995;15:38–47.PubMed Usberti M, Gazzotti RM, Poiesi C, D’Avanzo L, Ghielmi S. Considerations on the sodium retention in nephrotic syndrome. Am J Nephrol. 1995;15:38–47.PubMed
11.
Zurück zum Zitat Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med. 1979;91:688–96.PubMed Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med. 1979;91:688–96.PubMed
12.
Zurück zum Zitat Bohnert BN, Menacher M, Janessa A, et al. Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney Int. 2018;93:159–72.PubMed Bohnert BN, Menacher M, Janessa A, et al. Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney Int. 2018;93:159–72.PubMed
13.
Zurück zum Zitat Stæhr M, Buhl KB, Andersen RF, et al. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine. Am J Physiol Renal Physiol. 2015;309:F235–41.PubMed Stæhr M, Buhl KB, Andersen RF, et al. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine. Am J Physiol Renal Physiol. 2015;309:F235–41.PubMed
14.
Zurück zum Zitat Passero CJ, Hughey RP, Kleyman TR. New role for plasmin in sodium homeostasis. Curr Opin Nephrol Hypertens. 2010;19:13–9.PubMedPubMedCentral Passero CJ, Hughey RP, Kleyman TR. New role for plasmin in sodium homeostasis. Curr Opin Nephrol Hypertens. 2010;19:13–9.PubMedPubMedCentral
15.
Zurück zum Zitat Hughey RP, Mueller GM, Bruns JB, et al. Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits. J Biol Chem. 2003;278:37073–82.PubMed Hughey RP, Mueller GM, Bruns JB, et al. Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits. J Biol Chem. 2003;278:37073–82.PubMed
16.
Zurück zum Zitat Svenningsen P, Bistrup C, Friis UG, et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol. 2009;20:299–310.PubMedPubMedCentral Svenningsen P, Bistrup C, Friis UG, et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol. 2009;20:299–310.PubMedPubMedCentral
17.
Zurück zum Zitat Chen J-L, Wang L, Yao X-M, et al. Association of urinary plasminogen-plasmin with edema and epithelial sodium channel activation in patients with nephrotic syndrome. Am J Nephrol. 2019;50:92–104.PubMed Chen J-L, Wang L, Yao X-M, et al. Association of urinary plasminogen-plasmin with edema and epithelial sodium channel activation in patients with nephrotic syndrome. Am J Nephrol. 2019;50:92–104.PubMed
18.
Zurück zum Zitat Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron. 2000;85:194–200.PubMed Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron. 2000;85:194–200.PubMed
19.
Zurück zum Zitat Lagrue G, Branellec A, Blanc C, et al. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine. 1975;23:73–5.PubMed Lagrue G, Branellec A, Blanc C, et al. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine. 1975;23:73–5.PubMed
20.
Zurück zum Zitat Geers AB, Koomans HA, Roos JC, Boer P, Dorhout Mees EJ. Functional relationships in the nephrotic syndrome. Kidney Int. 1984;26:324–30.PubMed Geers AB, Koomans HA, Roos JC, Boer P, Dorhout Mees EJ. Functional relationships in the nephrotic syndrome. Kidney Int. 1984;26:324–30.PubMed
21.
Zurück zum Zitat Vande Walle J, Donckerwolcke R, Boer P, van Isselt HW, Koomans HA, Joles JA. Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int. 1996;49:1471–7.PubMed Vande Walle J, Donckerwolcke R, Boer P, van Isselt HW, Koomans HA, Joles JA. Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney Int. 1996;49:1471–7.PubMed
22.
Zurück zum Zitat Kapur G, Valentini RP, Imam AA, Mattoo TK. Treatment of severe edema in children with nephrotic syndrome with diuretics alone-a prospective study. Clin J Am Soc Nephrol. 2009;4:907–13.PubMedPubMedCentral Kapur G, Valentini RP, Imam AA, Mattoo TK. Treatment of severe edema in children with nephrotic syndrome with diuretics alone-a prospective study. Clin J Am Soc Nephrol. 2009;4:907–13.PubMedPubMedCentral
23.
Zurück zum Zitat Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet. 1995;346:148–52.PubMed Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet. 1995;346:148–52.PubMed
24.
Zurück zum Zitat Keenswijk W, Ilias MI, Raes A, Donckerwolcke R, Walle JV. Urinary potassium to urinary potassium plus sodium ratio can accurately identify hypovolemia in nephrotic syndrome: a provisional study. Eur J Pediatr. 2018;177:79–84.PubMed Keenswijk W, Ilias MI, Raes A, Donckerwolcke R, Walle JV. Urinary potassium to urinary potassium plus sodium ratio can accurately identify hypovolemia in nephrotic syndrome: a provisional study. Eur J Pediatr. 2018;177:79–84.PubMed
25.
Zurück zum Zitat Donckerwolcke RA, France A, Raes A, Vande WJ. Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol. 2003;59:259–66.PubMed Donckerwolcke RA, France A, Raes A, Vande WJ. Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol. 2003;59:259–66.PubMed
26.
Zurück zum Zitat Dönmez O, Mir S, Ozyürek R, Cura A, Kabasakal C. Inferior vena cava indices determine volume load in minimal lesion nephrotic syndrome. Pediatr Nephrol. 2001;16:251–5.PubMed Dönmez O, Mir S, Ozyürek R, Cura A, Kabasakal C. Inferior vena cava indices determine volume load in minimal lesion nephrotic syndrome. Pediatr Nephrol. 2001;16:251–5.PubMed
27.
Zurück zum Zitat Kosiak W, Swieton D, Piskunowicz M. Sonographic inferior vena cava/aorta diameter index, a new approach to the body fluid status assessment in children and young adults in emergency ultrasound--preliminary study. Am J Emerg Med. 2008;26:320–5.PubMed Kosiak W, Swieton D, Piskunowicz M. Sonographic inferior vena cava/aorta diameter index, a new approach to the body fluid status assessment in children and young adults in emergency ultrasound--preliminary study. Am J Emerg Med. 2008;26:320–5.PubMed
28.
Zurück zum Zitat Nalcacioglu H, Ozkaya O, Baysal K, et al. The role of bioelectrical impedance analysis, NT-ProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome. Nefrologia. 2018;38:48–56.PubMed Nalcacioglu H, Ozkaya O, Baysal K, et al. The role of bioelectrical impedance analysis, NT-ProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome. Nefrologia. 2018;38:48–56.PubMed
29.
Zurück zum Zitat Özdemir K, Mir MS, Dinçel N, et al. Bioimpedance for assessing volume status in children with nephrotic syndrome. Turk J Med Sci. 2015;45:339–44.PubMed Özdemir K, Mir MS, Dinçel N, et al. Bioimpedance for assessing volume status in children with nephrotic syndrome. Turk J Med Sci. 2015;45:339–44.PubMed
30.
Zurück zum Zitat Goodman LS, Brunton LL, Chabner B, Knollmann BC. Goodman & Gilman's Pharmacological Basis of Therapeutics, 14th ed. New York: McGraw-Hill; 2017. Goodman LS, Brunton LL, Chabner B, Knollmann BC. Goodman & Gilman's Pharmacological Basis of Therapeutics, 14th ed. New York: McGraw-Hill; 2017.
31.
Zurück zum Zitat Ellison DH. Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol. 2019;14:1248–57.PubMed Ellison DH. Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol. 2019;14:1248–57.PubMed
32.
Zurück zum Zitat Ali F, Guglin M, Vaitkevicius P, Ghali JK. Therapeutic potential of vasopressin receptor antagonists. Drugs. 2007;67:847–58.PubMed Ali F, Guglin M, Vaitkevicius P, Ghali JK. Therapeutic potential of vasopressin receptor antagonists. Drugs. 2007;67:847–58.PubMed
33.
Zurück zum Zitat Shimizu M, Ishikawa S, Yachi Y, et al. Tolvaptan therapy for massive edema in a patient with nephrotic syndrome. Pediatr Nephrol. 2014;29:915–7.PubMed Shimizu M, Ishikawa S, Yachi Y, et al. Tolvaptan therapy for massive edema in a patient with nephrotic syndrome. Pediatr Nephrol. 2014;29:915–7.PubMed
34.
Zurück zum Zitat Meena J, Sinha A, Hari P, Bagga A. Therapy with the combination of tolvaptan and furosemide for refractory edema in nephrotic syndrome. Indian J Nephrol. 2020;30:53–5.PubMed Meena J, Sinha A, Hari P, Bagga A. Therapy with the combination of tolvaptan and furosemide for refractory edema in nephrotic syndrome. Indian J Nephrol. 2020;30:53–5.PubMed
36.
Zurück zum Zitat Fliser D, Zurbrüggen I, Mutschler E, et al. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629–34.PubMed Fliser D, Zurbrüggen I, Mutschler E, et al. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629–34.PubMed
37.
Zurück zum Zitat Akcicek F, Yalniz T, Basci A, Ok E, Mees EJ. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? BMJ. 1995;310:162–3.PubMedPubMedCentral Akcicek F, Yalniz T, Basci A, Ok E, Mees EJ. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? BMJ. 1995;310:162–3.PubMedPubMedCentral
38.
Zurück zum Zitat Na KY, Han JS, Kim YS, et al. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome? J Korean Med Sci. 2001;16:448–54.PubMedPubMedCentral Na KY, Han JS, Kim YS, et al. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome? J Korean Med Sci. 2001;16:448–54.PubMedPubMedCentral
39.
Zurück zum Zitat Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N. Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Saudi J Kidney Dis Transplant. 2011;22:471–5. Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N. Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Saudi J Kidney Dis Transplant. 2011;22:471–5.
40.
Zurück zum Zitat Phakdeekitcharoen B, Boonyawat K. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study. BMC Nephrol. 2012;13:92.PubMedPubMedCentral Phakdeekitcharoen B, Boonyawat K. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study. BMC Nephrol. 2012;13:92.PubMedPubMedCentral
41.
Zurück zum Zitat Dharmaraj R, Hari P, Bagga A. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol. 2009;24:775–82.PubMed Dharmaraj R, Hari P, Bagga A. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol. 2009;24:775–82.PubMed
42.
Zurück zum Zitat Ho JJ, Adnan AS, Kueh YC, Ambak NJ, Van Rostenberghe H, Jummaat F. Human albumin infusion for treating oedema in people with nephrotic syndrome. Cochrane Database Syst Rev. 2019;7:CD009692.PubMed Ho JJ, Adnan AS, Kueh YC, Ambak NJ, Van Rostenberghe H, Jummaat F. Human albumin infusion for treating oedema in people with nephrotic syndrome. Cochrane Database Syst Rev. 2019;7:CD009692.PubMed
43.
Zurück zum Zitat Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics. 1993;91:1142–6.PubMed Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics. 1993;91:1142–6.PubMed
44.
Zurück zum Zitat Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7:216–34. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7:216–34.
45.
Zurück zum Zitat McCaffrey J, Lennon R, Webb NJA. The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol. 2016;31:1383–402.PubMed McCaffrey J, Lennon R, Webb NJA. The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol. 2016;31:1383–402.PubMed
46.
Zurück zum Zitat Hoorn EJ, Ellison DH. Diuretic resistance. Am J Kidney Dis. 2017;69:136–42.PubMed Hoorn EJ, Ellison DH. Diuretic resistance. Am J Kidney Dis. 2017;69:136–42.PubMed
Metadaten
Titel
Current Perspectives in Management of Edema in Nephrotic Syndrome
verfasst von
Jitendra Meena
Arvind Bagga
Publikationsdatum
30.03.2020
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 8/2020
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-020-03252-9

Weitere Artikel der Ausgabe 8/2020

The Indian Journal of Pediatrics 8/2020 Zur Ausgabe

Mehr Zeit in den sozialen Medien kann zu Angststörungen führen

Eine Studie aus Finnland hat die Social-Media-Nutzung unter 16-jährigen Mädchen genauer unter die Lupe genommen. Lange Nutzdauer von Instagram & Co. war mit höheren Raten an Angststörungen assoziiert. Insgesamt waren rund 17% der Mädchen abhängig von Social Media.

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.